Comparative Pharmacology
Head-to-head clinical analysis: INTRALIPID 10 versus LIPOSYN II 20.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INTRALIPID 10 versus LIPOSYN II 20.
INTRALIPID 10% vs LIPOSYN II 20%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intralipid 10% is a fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of energy. It acts as a carrier for fat-soluble vitamins and prevents essential fatty acid deficiency. The mechanism involves direct utilization of triglycerides for energy after hydrolysis by lipoprotein lipase.
Lipid emulsion providing essential fatty acids (linoleic and linolenic acids) and calories for parenteral nutrition. The triglycerides are hydrolyzed by lipoprotein lipase to free fatty acids and glycerol, which are then utilized for energy or stored.
Intravenous infusion. Adult: 500 mL of 10% emulsion (50 g fat) over 4-6 hours, up to 2.5 g fat/kg/day. Maximum infusion rate: 0.1 g fat/kg/hour.
Intravenous fat emulsion; 20% formulation: Initial rate 1 mL/min for 15-30 minutes, then increase to 2 mL/min if tolerated. Max infusion rate: 100 mL/hour. Total daily dose: 1-2 g/kg (5-10 mL/kg) to provide up to 60% of nonprotein calories.
None Documented
None Documented
The terminal elimination half-life of Intralipid triglycerides is approximately 30-60 minutes in adults with normal lipid metabolism. In neonates and patients with impaired clearance, half-life may be prolonged to 2-4 hours. Clinical context: half-life increases with infusion rate; at steady state, clearance is rapid due to extrahepatic lipolysis.
Terminal elimination half-life of triglycerides is approximately 30 minutes for the fast phase and 12-24 hours for the slow phase, reflecting clearance from plasma and tissue distribution.
Intralipid 10% (IV fat emulsion) is metabolized like endogenous chylomicrons; elimination is not via renal or biliary routes. Triglycerides are hydrolyzed by lipoprotein lipase, and the resulting free fatty acids are taken up by tissues. Less than 0.5% is excreted unchanged in urine. Biliary excretion of metabolites is negligible.
Intravenous lipid emulsions are metabolized by lipoprotein lipase and eliminated as free fatty acids; less than 1% excreted unchanged in urine, negligible biliary/fecal excretion.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion